Literature DB >> 28992656

[SOP - Standarized procedures in diagnostics and therapies of periocular basal cell carcinoma].

Vinodh Kakkassery, Ludwig M Heindl.   

Abstract

The basal cell carcinoma (BCC) is the malignant eye tumor with the highest incidence. The aim of this article is to present a systematic and standardized approach to diagnose, treat and care periocular basal cell carcinoma. Interpretation of clinical signs, diagnostic tools to identify periocular BCC and interpretation lead to the appropriate choice of therapy. Surgical removal with a histological R0 resection is an important component of therapy options in this disease and includes the microsurgical excision into healthy tissue and the subsequent covering of the defect. Alternative treatment options are targeted therapies with hedgehog inhibitors and beam radiation in excessive basal cell carcinoma. Also, aftercare of patients with basal cell carcinoma follows the treatment. A special focus of this article is the treatment of locally extensive and metastasized BCC and the national S2 guidelines of this tumor. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Year:  2017        PMID: 28992656     DOI: 10.1055/s-0043-120086

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  5 in total

Review 1.  [Surgical resection with ophthalmoplastic reconstruction : Gold standard in periocular basal cell carcinoma].

Authors:  A C Rokohl; A Kopecky; Y Guo; V Kakkassery; J M Mor; N Loreck; K R Koch; L M Heindl
Journal:  Ophthalmologe       Date:  2020-02       Impact factor: 1.059

2.  [Periocular basal cell carcinoma].

Authors:  Ludwig M Heindl
Journal:  Ophthalmologe       Date:  2020-02       Impact factor: 1.059

3.  [Young male patient with unusual space-occupying lesion of the lower eyelid].

Authors:  Alexander C Rokohl; Heike Löser; Joel M Mor; Niklas Loreck; Konrad R Koch; Ludwig M Heindl
Journal:  Ophthalmologe       Date:  2020-01       Impact factor: 1.059

Review 4.  [Alternative treatment options for periorbital basal cell carcinoma].

Authors:  Vinodh Kakkassery; Steffen Emmert; Irenäus A Adamietz; György Kovács; Anselm M Jünemann; Caroline Otte; Michael Zimbelmann; Anton Brosig; Salvatore Grisanti; Ludwig M Heindl
Journal:  Ophthalmologe       Date:  2020-02       Impact factor: 1.059

5.  [Advanced periocular basal cell carcinoma-a therapeutic challenge].

Authors:  B Lauterbach; V Kakkassery; D Debus; L M Heindl; E S Schultz
Journal:  Ophthalmologe       Date:  2019-03       Impact factor: 1.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.